• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Privia Health Group Inc.

    3/27/26 11:20:57 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care
    Get the next $PRVA alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 2)


    Privia Health Group Inc

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)




    74276R102

    (CUSIP Number)
    03/13/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    74276R102


    1Names of Reporting Persons

    The Vanguard Group
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    PENNSYLVANIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    0.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    IA

    Comment for Type of Reporting Person:   On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Privia Health Group Inc
    (b)Address of issuer's principal executive offices:

    950 North Glebe Road, Suite 700, Arlington, VA, 22203
    Item 2. 
    (a)Name of person filing:

    The Vanguard Group
    (b)Address or principal business office or, if none, residence:

    100 Vanguard Blvd.,, Malvern, PA, 19355
    (c)Citizenship:

    PA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    0
    (b)Percent of class:

    0  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    The Vanguard Group
     
    Signature:Ashley Grim
    Name/Title:Head of Global Fund Administration
    Date:03/27/2026
    Get the next $PRVA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRVA

    DatePrice TargetRatingAnalyst
    1/9/2026$31.00Outperform
    RBC Capital Mkts
    11/13/2025$30.00Outperform
    BMO Capital Markets
    1/10/2025$25.00Buy
    Needham
    12/16/2024Outperform
    Macquarie
    10/11/2024$23.00Overweight
    KeyBanc Capital Markets
    5/30/2024$23.00Outperform
    Robert W. Baird
    4/22/2024$25.00Buy
    Citigroup
    3/6/2024$22.00Equal Weight
    Barclays
    More analyst ratings

    $PRVA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence

    ARLINGTON, Va., March 24, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2026 MAP (Measure, Apply, Perform) Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association (HFMA). Privia Health has been recognized by HFMA for its revenue cycle capabilities and performance in nine of the last ten years. The MAP Award is one of the healthcare industry's most respected distinctions, highlighting organizations that demonstrate sustained excellence across key revenue cycle metrics, including net collection rat

    3/24/26 9:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

    Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale. Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia Health (NASDAQ:PRVA)-led colorectal cancer (CRC) screening program, supported by Amalgam Rx, Inc. and Exact Sciences Corp. (NASDAQ:EXAS). Documented in a published Privia Health case study, the program demonstrates how EHR-integrated workflows and proactive patient outreach supported an increase of CRC screening rates to 84% in 2024, exceeding national benchmarks and surpassing the Natio

    3/3/26 10:00:00 AM ET
    $EXAS
    $PRVA
    Medical Specialities
    Health Care
    Medical/Nursing Services

    Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results

    All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year 2025 Net Cash Provided by Operating Activities of $163.4 Million, +49.5% from 2024; Year-end 2025 Cash Balance of $479.7 Million and No Debt2026 Guidance Reflects ~20% Adjusted EBITDA Growth at Midpoint ARLINGTON, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Each of the Company's operating and financial performance metrics were at or above the high end

    2/26/26 6:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Mountcastle David

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    3/18/26 4:07:16 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Mehrotra Parth

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    3/18/26 4:06:45 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    EVP & Chief Financial Officer Mountcastle David sold $282,600 worth of shares (13,018 units at $21.71), decreasing direct ownership by 5% to 226,804 units (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    3/16/26 4:17:11 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Privia Health Group Inc.

    SCHEDULE 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    3/27/26 11:20:57 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Privia Health Group Inc.

    144 - Privia Health Group, Inc. (0001759655) (Subject)

    3/12/26 4:14:41 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Privia Health Group Inc.

    144 - Privia Health Group, Inc. (0001759655) (Subject)

    3/9/26 4:01:51 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Boehler Adam bought $6,006 worth of shares (364 units at $16.50) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    6/13/24 4:05:22 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Boehler Adam bought $87,549 worth of shares (5,306 units at $16.50) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    5/31/24 4:13:08 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Boehler Adam bought $70,577 worth of shares (4,280 units at $16.49) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    5/29/24 4:08:14 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Privia Health with a new price target

    RBC Capital Mkts initiated coverage of Privia Health with a rating of Outperform and set a new price target of $31.00

    1/9/26 8:12:05 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on Privia Health with a new price target

    BMO Capital Markets initiated coverage of Privia Health with a rating of Outperform and set a new price target of $30.00

    11/13/25 9:16:05 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Needham initiated coverage on Privia Health with a new price target

    Needham initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00

    1/10/25 7:58:16 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Financials

    Live finance-specific insights

    View All

    Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results

    All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year 2025 Net Cash Provided by Operating Activities of $163.4 Million, +49.5% from 2024; Year-end 2025 Cash Balance of $479.7 Million and No Debt2026 Guidance Reflects ~20% Adjusted EBITDA Growth at Midpoint ARLINGTON, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Each of the Company's operating and financial performance metrics were at or above the high end

    2/26/26 6:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26

    ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods ended December 31, 2025 before market open on Thursday, February 26, 2026. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, February 26, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-a

    1/22/26 9:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Privia Health Reports Third Quarter 2025 Financial Results

    Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q'24FY'25 Guidance Raised Above High End for All Key Operating and Financial Metrics ARLINGTON, Va., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter ended September 30, 2025. Third Quarter Performance   For the Three Months Ended September 30,  ($ in millions, except per share amounts)  2025  2024 Change (%) fTotal revenue $580.4 $437.9 32.5%Gross profit $122.6 $99.9 22.7%Operating income $14.4 $5.8 1

    11/6/25 6:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Leadership Updates

    Live Leadership Updates

    View All

    Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health

    ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. (NYSE:EVH). The ACO business cares for over 120,000 attributed lives through the Medicare Shared Savings Program (MSSP), as well as various commercial and Medicare Advantage programs. With this transaction, Privia Health will now serve approximately 1.5 million attributed lives in value-based care (VBC) arrangements across commercial, Medicare, Medicare Advantage and Medicaid. Privia Health will pay $100 million in cash at closing and up to an additional $13 million su

    9/23/25 4:10:00 PM ET
    $EVH
    $PRVA
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors

    ARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. "We are excited to welcome Lance to our Board of Directors," said David King, Chairman of the Board, Privia Health Group, Inc. "Lance brings extensive technology strategy and digital transformation experience to the Board, including IT governance, infrastructure management and cybersecurity. We believe his expertise will be invaluable to Privia Health as

    7/8/25 9:00:00 AM ET
    $LH
    $PRVA
    Medical Specialities
    Health Care
    Medical/Nursing Services

    Privia Health Appoints Edward C. Fargis as General Counsel

    ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us

    1/29/24 8:30:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    11/14/24 5:20:21 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    11/12/24 10:34:17 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    7/10/24 1:14:41 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care